20 YEARS OF PROFESSIONAL & DEDICATED SERVICE TO GLOBAL CUSTOMERS

Custom Manufacturing, Project Outsourcing, your Trusted Partner from China

Understanding the Specifications: CAS 90776-58-2 for Your Synthesis Needs

For professionals in chemical synthesis and pharmaceutical manufacturing, understanding the detailed specifications of crucial intermediates is fundamental to successful outcomes. (3S,4S)-3-[(R)-1-(tert-Butyldimethylsilyloxy)ethyl]-4-[(R)-1-carboxyethyl]-2-azetidinone, identified by CAS number 90776-58-2, is one such compound, serving as a vital precursor in the synthesis of advanced carbapenem antibiotics.

This chiral intermediate possesses a defined molecular formula (C14H27NO4Si) and molecular weight (301.45 g/mol), critical parameters for stoichiometric calculations in complex organic reactions. Information regarding its physical appearance, typically a solid, and solubility characteristics is vital for process design and optimization. Pharmaceutical manufacturers and chemical researchers often look for suppliers who provide comprehensive documentation, including detailed Certificates of Analysis (CoAs) that confirm purity levels, identify potential impurities, and specify storage conditions (often recommended as 2-8°C in a cool, dark place).

When intending to buy (3S,4S)-3-[(R)-1-(tert-Butyldimethylsilyloxy)ethyl]-4-[(R)-1-carboxyethyl]-2-azetidinone, it is important to consider the source. Manufacturers specializing in fine chemicals and pharmaceutical intermediates are best positioned to meet the stringent quality requirements for such compounds. Whether you are a research scientist requiring small quantities for early-stage development or a procurement manager sourcing bulk material for commercial production, partnering with a reliable supplier is essential.

Engaging with manufacturers directly often provides clearer insights into their production capabilities and quality control measures. Companies seeking a dependable supplier for this key intermediate are encouraged to reach out to established chemical companies, particularly those with a strong reputation for producing high-purity chiral compounds. Understanding the specifications and sourcing reliably ensures that your synthetic processes can proceed efficiently and effectively.

Manufacturing Facilities

NINGBO INNO PHARMCHEM CO.,LTD. was established in 2007. It is committed to the R&D, production and sales of raw materials, pharmaceutical intermediates and fine chemicals. We striving to create a high-efficiency and high-quality integrated chemical service platform to better serve domestic and foreign customers.

Professional Export Experience

to Global Customers

WHY CHOSE US?

1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;

2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;

3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).

FAQ

  • A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.

  • A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.

  • A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.

CONTACT US
Should you need to contact us; you may call during regular business hours, Monday through Friday, 8am – 6 pm.
NINGBO INNO PHARMCHEM CO.,LTD.
Address: No.163 Ruiqing Rd.,Ningbo 315000 China
Phone: 86-574-87319282
Fax: 86-574-27912196
SEND US AN EMAIL

NAME*

EMAIL*

COMPANY

COUNTRY*

MESSAGE*

Previous: Key Building Blocks: The Role of Azetidinone Derivatives in Antibiotic Development

Next: Sourcing High-Purity Ribofuranose Derivatives: A Guide for Pharmaceutical Buyers

All Rights Reserved